Enphasys granted US patent

December 6, 2022

Enphasys has today been granted US patent for the Enabling Absorption Device. The ENA monitors digestion, dissolution/release and permeation in the same assay and correctly ranks in vivo performance of advanced drug formulations. The technology may replace animal experiments in drug formulation development, save cost and reduce time to market

© 2022 Enphasys AB. All right reserved.  Phent
EU loggo
This project has recieved funding by the European Union's Horizon 2020 research and innovation programme under grant agreement No 836869
Vinnova loggo white